Results 151 to 160 of about 448,583 (189)
Genomic and transcriptomic features of HBV integration in treatment-naïve, HBeAg-positive children with chronic HBV infection. [PDF]
Wu N +23 more
europepmc +1 more source
Pan-cancer single-cell transcriptomic analysis reveals CD83 as a hallmark of tumor-associated neutrophils with senescent and pro-tumor properties. [PDF]
Wang Y +16 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Expression of Scophthalmus maximus CD83 Correlates With Bacterial Infection and Antigen Stimulation
Fish and Shellfish Immunology, 2010CD83 is a transmembrane glycoprotein of the immunoglobulin (Ig) superfamily and a surface marker for fully matured dendritic cells (DCs) in humans and mice. In teleosts, DC-like cells and their molecular markers are largely unknown. In this report, we described the identification and expressional analysis of a CD83 homologue, SmCD83, from turbot ...
Li Sun, Yong-Hua Hu
exaly +3 more sources
Hodgkin’s Cells Express CD83, a Dendritic Cell Lineage Associated Antigen
Pathology, 1997Hodgkin's cells (HC) are considered to be the malignant cells of Hodgkin's disease (HD), but despite extensive studies, no conclusive evidence has emerged regarding their non-malignant counterpart and the ontogeny of these cells remains controversial. The analysis of a possible dendritic cell (DC) origin of HC has been hampered to date by the lack of a
Bridget Robinson, Barry Hock, Derek Hart
exaly +3 more sources
Following T-cell receptor and CD28 signaling, CD8+ T cells express a receptor for CD83, a molecule up-regulated on functionally mature dendritic cells. Although this expression pattern suggests that CD83 is involved in adaptive immunity, little is known about its function in the periphery, and the existence of its ligand on T cells is controversial. We
Gordon J. Freeman +2 more
exaly +4 more sources
Clinical Lymphoma Myeloma and Leukemia, 2021
Context and Objective CD83 is expressed on activated CD4+ T-cells, dendritic cells, and acute myeloid leukemia (AML), but its expression level on organ-specific normal tissue is not well investigated. A novel human CD83-targeted CAR T-cell has been developed and shown in preclinical work to treat and prevent graft-versus-host disease (GVHD) and confer
Tony Kurian +4 more
openaire +1 more source
Context and Objective CD83 is expressed on activated CD4+ T-cells, dendritic cells, and acute myeloid leukemia (AML), but its expression level on organ-specific normal tissue is not well investigated. A novel human CD83-targeted CAR T-cell has been developed and shown in preclinical work to treat and prevent graft-versus-host disease (GVHD) and confer
Tony Kurian +4 more
openaire +1 more source
Journal of Comparative Neurology, 2009
AbstractCells recruited by the innate immune response rely on surface‐expressed molecules in order to receive signals from the local environment and to perform phagocytosis, cell adhesion, and others processes linked to host defense. Hundreds of surface antigens designated through a cluster of differentiation (CD) number have been used to identify ...
Isaias, Glezer +2 more
openaire +2 more sources
AbstractCells recruited by the innate immune response rely on surface‐expressed molecules in order to receive signals from the local environment and to perform phagocytosis, cell adhesion, and others processes linked to host defense. Hundreds of surface antigens designated through a cluster of differentiation (CD) number have been used to identify ...
Isaias, Glezer +2 more
openaire +2 more sources

